Founded Year

2014

Stage

Incubator/Accelerator | Alive

Total Raised

$66.38M

About Healx

Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments. Its AI drug discovery platform leverages public and proprietary biomedical data and features a knowledge graph for rare diseases.

Healx Headquarter Location

Charter House, 66-68 Hills Rd

Cambridge, England, CB2 1LA,

United Kingdom

+44 1223 707068

ESPs containing Healx

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare / Biopharmaceuticals

AI drug discovery vendors are analyzing data (e.g., clinical trials data, EHRs, omics data, cellular images, and more) to develop novel drugs.

Healx named as Outperformer among 9 other companies, including Atomwise, Insilico Medicine, and insitro.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Healx's Products & Differentiation

See Healx's products and how their products differentiate from alternatives and competitors

  • Indication expansion

    New rare or common disease predictions for human safe compounds. Our technology can be applied to marketed, development or shelved compounds. Healx performs prediction and early pharmacological validation of predictions.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Research containing Healx

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Healx in 3 CB Insights research briefs, most recently on May 17, 2022.

Expert Collections containing Healx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Healx is included in 6 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

8,717 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

D

Digital Health 150

150 items

The winners of the second annual CB Insights Digital Health 150.

O

Omics

1,265 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

D

Digital Health

12,812 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

B

Biopharma Tech

838 items

A

AI 100

100 items

Healx Patents

Healx has filed 6 patents.

The 3 most popular patent topics include:

  • Neurological disorders
  • Syndromes
  • Autism
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/12/2019

12/15/2020

Psychiatric diagnosis, Autism, Rare diseases, Syndromes, Neurological disorders

Grant

Application Date

4/12/2019

Grant Date

12/15/2020

Title

Related Topics

Psychiatric diagnosis, Autism, Rare diseases, Syndromes, Neurological disorders

Status

Grant

Latest Healx News

Healx Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Healx Rank

  • When was Healx founded?

    Healx was founded in 2014.

  • Where is Healx's headquarters?

    Healx's headquarters is located at Charter House, 66-68 Hills Rd, Cambridge.

  • What is Healx's latest funding round?

    Healx's latest funding round is Incubator/Accelerator.

  • How much did Healx raise?

    Healx raised a total of $66.38M.

  • Who are the investors of Healx?

    Investors of Healx include Tech Nation Fintech, Jonathan Milner, Amadeus Capital Partners, Balderton Capital, Intel Capital and 6 more.

  • Who are Healx's competitors?

    Competitors of Healx include BenevolentAI, Verge Genomics, Biotx.ai, Exscientia, Standigm and 14 more.

  • What products does Healx offer?

    Healx's products include Indication expansion and 3 more.

  • Who are Healx's customers?

    Customers of Healx include Ovid Therapeutics.

You May Also Like

B
BERG

BERG is a Boston-based biopharma company focused on taking a bold "back to biology" approach to therapeutic discovery using its unique AI-based Interrogative Biology platform. This platform combines patient biology and artificial intelligence-based analytics to engage the differences between healthy and disease environments. The patient's own biology drives the platform's results and guides the company in the discovery and development of drugs, diagnostics and healthcare applications. Its platform utilizes patient population health data to bring actionable Patient Intelligence to precision medicine applications. This means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems.

insitro Logo
insitro

insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients.

GNS Healthcare Logo
GNS Healthcare

GNS Healthcare applies artificial intelligence (AI) platform to unravel the complexity of human disease in order to match the right treatment to the right patient at the right time.

Standigm Logo
Standigm

Standigm is an AI and systems biology-based startup that aims to expedite the drug discovery process. Standigm develops a computer modeling technology that learns medical and biological information and predicts the action mechanism of pharmaceutics in advance. This technology can improve the pharmaceutical development process by tailoring the application of previous know-hows, come up with possible combinations of pharmaceuticals, and optimize the selection of candidates and participants for clinical trials.

Aria Pharmaceuticals Logo
Aria Pharmaceuticals

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company that discovers and develops novel small molecule therapies for complex and hard-to-treat diseases

Insilico Medicine Logo
Insilico Medicine

Insilico Medicine is an artificial intelligence company headquartered in Hong Kong developing a range of generative adversarial networks (GANs) and reinforcement learning approaches to identify protein targets, generate molecular structures with specified properties and generate synthetic data.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.